Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Advances in RNA Therapeutics for Human Diseases
Hannah Zogg, Rajan Singh, Seungil Ro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2736-2736
Open Access | Times Cited: 127

Showing 26-50 of 127 citing articles:

Types of RNA therapeutics
Pouya Goleij, Mehregan Babamohamadi, Aryan Rezaee, et al.
Progress in molecular biology and translational science (2024), pp. 41-63
Closed Access | Times Cited: 5
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor
Yi Li, José L. Mondaza-Hernández, David S. Moura, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102154-102154
Open Access | Times Cited: 5
Osteosarcoma in a ceRNET perspective
Nicola Mosca, Nicola Alessio, Alessandra Di Paola, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
Pauline van Schaik, Inge S. Zuhorn, Wia Baron
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8418-8418
Open Access | Times Cited: 19
Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis
Deborah D. Chin, Neil Patel, Woori Lee, et al.
Bioactive Materials (2023) Vol. 27, pp. 327-336
Open Access | Times Cited: 12
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 12
Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs
Yue-Yu Gu, Xu‐Sheng Liu, Hui Y. Lan
Molecular Therapy (2023) Vol. 32, Iss. 2, pp. 313-324
Open Access | Times Cited: 12
miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes
Hannah Zogg, Rajan Singh, Se Eun Ha, et al.
United European Gastroenterology Journal (2023) Vol. 11, Iss. 8, pp. 750-766
Open Access | Times Cited: 11
RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment
Anjana Goel, Amisha Rastogi, M. Jain, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2125-2137
Closed Access | Times Cited: 4
Isoprenoid CARTs: In Vitro and In Vivo mRNA Delivery by Charge-Altering Releasable Transporters Functionalized with Archaea-inspired Branched Lipids
Harrison P. Rahn, Jiuzhi Sun, Z. Li, et al.
Biomacromolecules (2024) Vol. 25, Iss. 7, pp. 4305-4316
Closed Access | Times Cited: 4
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives
Majid Nazari, Emad Babakhanzadeh, Arghavan Mollazadeh, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Potential of mRNA therapy in the treatment of cardiovascular diseases
К. А. Айтбаев, И. Т. Муркамилов, В. В. Фомин
Clinical Medicine (Russian Journal) (2025) Vol. 102, Iss. 8, pp. 585-592
Open Access
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA
Eliot A. Brinton, Robert H. Eckel, Daniel Gaudet, et al.
Atherosclerosis (2025), pp. 119114-119114
Closed Access
RNA research for drug discovery: Recent advances and critical insight
Patrick Maduabuchi Aja, Peter Chinedu Agu, Celestine O. Ogbu, et al.
Gene (2025) Vol. 947, pp. 149342-149342
Closed Access
siRNA-based Delivery Systems: Technologies, Carriers, Applications, and Approved Products
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
European Journal of Pharmacology (2025), pp. 177441-177441
Closed Access
Lipid-based nanoparticles for nucleic acids delivery
Sonia Sarnelli, Michael Cardamone, Ernesto Reverchon, et al.
Physical Sciences Reviews (2025)
Closed Access
RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management
Abbas Mohammadi, Azin Karimian, Kasra Shokri, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access
The Interplay of Endosomal Escape and RNA Release from Polymeric Nanoparticles
Timothy H. Cheung, Molly S. Shoichet
Langmuir (2025)
Closed Access
Delivering RNA through exosomes for cancer therapy
Tianming Zhao, Jinping Wang
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 4
Closed Access
The impact of rare diseases on the quality of life in paediatric patients: current status
John Sieh Dumbuya, Cizheng Zeng, Linhong Deng, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
microRNAs in Type 1 Diabetes: Roles, Pathological Mechanisms, and Therapeutic Potential
H. Cho, Se Eun Ha, Rajan Singh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3301-3301
Open Access
Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy
Mahdi Rahimi, Zahra Kariminezhad, Elsa-Patricia Rondon, et al.
Carbohydrate Polymers (2025), pp. 123581-123581
Closed Access
Pragmatic Clinical Methods, Tools and Amplification Techniques Used in RNA-Based Diagnostic Applications
Anuja Pant, Ganesh S. Kakde, Pawan Kumar Maurya
(2025), pp. 265-281
Closed Access
Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
Blaine A. Pfeifer, Marie Beitelshees, Andrew Hill, et al.
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer
Imran Kazmi, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155134-155134
Closed Access | Times Cited: 3

Scroll to top